SARS‐CoV‐2 infection can cause severe pneumonia (COVID‐19). There is evidence that
patients with comorbidities are at higher risk of a severe disease course. The role of …

COVID-19 is a pandemic disease that causes severe pulmonary damage and hyperinflammation.
Vitamin A is a crucial factor in the development of immune functions and is known to …

With increasing numbers of patients recovering from COVID-19, there is increasing evidence
for persistent symptoms and the need for follow-up studies. This retrospective study …

The clinical course of COVID-19 is very heterogeneous: most infected individuals can be
managed in an outpatient setting, but a substantial proportion of patients requires intensive care…

Objective Infection with the novel coronavirus SARS–CoV‐2 triggers severe illness with
high mortality in a subgroup of patients. Such a critical course of COVID‐19 is thought to be …

Understanding the course of the antibody response directed to individual epitopes of SARS-CoV-2
proteins is crucial for serological assays and establishment of vaccines. Twenty-one …

Background The vast majority of COVID-19 patients experience a mild disease. However, a
minority suffers from critical disease with substantial morbidity and mortality. Objectives To …

Severe acute respiratory syndrome coronovirus-2 (SARS-CoV-2) is the cause of the coronavirus
disease 2019 (COVID-19) pandemic. Vaccination is considered the core approach to …

The COVID-19 pandemic is caused by the SARS CoV-2 virus and can lead to severe lung
damage and hyperinflammation. In the context of COVID-19 infection, inflammation-induced …

Background: The prone position (PP) is increasingly used in mechanically ventilated
coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS) patients. …